Cambridge Collaborative (United States)

Recent papers from Cambridge Collaborative (United States)

1. Consensus Recommendations for Patients with Complex Dispositions: A Modified Delphi Study Among the Strengthening Essential Emergency Departments (SEED)Journal of the American College of Emergency Physicians Open · 2026
2. Multicenter Evaluation of Noise Levels and Staff Perceptions Across Laser Technologies During Holmium Laser Enucleation of the Prostate: A Prostate Enucleation Collaborative InitiativeLasers in Surgery and Medicine · 2026
3. Deferred climate-related migrationFrontiers in Climate · 2026
4. Schools Know Best: Organisational development coaching as an underdeveloped practice in schools: a research synthesis2026
5. Schools Know Best: Organisational development coaching as an underdeveloped practice in schools: a research synthesis2026
6. A Validated Prognostic Score for Time to Loss of Ambulation in Patients With Duchenne Muscular DystrophyNeurology · 2026
7. A phase 1 study of BGB-A3055 (anti-CCR8) with or without tislelizumab (anti–PD-1) in patients with solid tumors.Journal of Clinical Oncology · 2026
8. A phase 1 study of BGB-B2033 (GPC3 x 4-1BB bispecific antibody) monotherapy in patients with selected advanced or metastatic solid tumors: First disclosure of clinical data.Journal of Clinical Oncology · 2026
9. 54 Erionite-induced carcinogenicity: mechanistic insights and comparative potency with asbestosAnnals of Work Exposures and Health · 2026
10. Perceptions of Racism and Discrimination in Birthing Centers: Implications for Exclusive Breastfeeding Practices Among Black MothersJournal of Human Lactation · 2026
11. Never-ending Acronym Madness: Proposing a harmonized definition for NAMsNAM journal. · 2026
12. Pulmonary Rehabilitation is Associated with Increased 1-Year Survival in Stable COPDAmerican Journal of Respiratory and Critical Care Medicine · 2026
13. Analysis of error profiles of indels and structural variants in deep-sequencing dataCell Genomics · 2025
14. A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti–PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation resultsCancer Chemotherapy and Pharmacology · 2025
15. Descriptive characterization of ambulatory health states in Duchenne muscular dystrophy: Motor function trajectories and times to loss of ambulationJournal of Neuromuscular Diseases · 2025
16. Using community‐based system dynamics to understand connections between housing and education: A case study with implications for homelessness prevention school‐housing partnershipAmerican Journal of Community Psychology · 2025
17. Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophyPLoS ONE · 2025
18. Cellular defense mechanisms against asbestos fibersFrontiers in Public Health · 2025
19. Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatmentsThe American Journal of Human Genetics · 2025
20. Visualizing ambulatory performance by age and rates of decline among patients with Duchenne muscular dystrophyJournal of Neuromuscular Diseases · 2025